Radiology workflow software program firm Sirona Medical has acquired $42 million in Collection C financing, bringing complete funding raised to $100 million. The corporate additionally named a brand new CEO.
Avidity Companions, a participant within the beforehand introduced Collection B financing, led this spherical with further participation from different current traders, together with 8VC, and GreatPoint Ventures.
San Francisco-based Sirona mentioned its Unify platform unifies diagnostic and scientific picture viewing, radiology reporting, worklist, and AI (together with impression technology) on a single cloud-native platform.
The Unify platform will be deployed as an overlay to current on-premises methods (PACS and RIS), permitting radiology practices that service a number of hospitals and well being methods to mix disparate workflows right into a single unified workflow expertise.
The brand new capital will help business enlargement in addition to the continued evolution of the Unify platform, notably round workflow effectivity and AI-powered report technology.
Hooman Hakami, who has served as a senior government at GE Healthcare and Medtronic, has been appointed CEO. Cameron Andrews, Sirona’s founder, will stay concerned in his new position as president.
“We’re getting into the following part within the firm’s maturity and skill to ship our next-generation resolution to a broader viewers whereas supporting the success of each buyer,” mentioned Andrews, in a press release.
“The Sirona imaginative and prescient is compelling. Cameron and all the crew have achieved a superb job attaining a degree of workflow integration throughout a number of platforms that no different firm has reached in radiology IT. I stay up for working alongside Cameron and all the Sirona crew as we enter this new development part,” mentioned Hakami in a press release.
Sirona Medical is led by a crew of software program engineers, knowledge scientists, and radiology professionals together with Alan Kaye, M.D., chief medical officer and former president of the American Faculty of Radiology (ACR), in addition to trade veterans from Sectra, Arterys, R2 Applied sciences, and others. Notable advisors embrace Curt Langlotz, M.D., Ph.D., director on the Heart for Synthetic Intelligence in Medication and Imaging (AIMI) at Stanford College; Chris Wooden, former CTO at Intelerad; Ron Paulus, former CEO at Mission Well being, and; Bob Baumgartner, retired government chairman of the board on the Heart for Diagnostic Imaging.
